The Manufacturers Life Insurance Company Has $7.43 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

The Manufacturers Life Insurance Company increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 298,437 shares of the medical instruments supplier’s stock after acquiring an additional 14,802 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.14% of DENTSPLY SIRONA worth $7,434,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in XRAY. LRI Investments LLC grew its holdings in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares during the period. Rothschild Investment LLC acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth $32,000. Central Pacific Bank Trust Division bought a new stake in DENTSPLY SIRONA in the first quarter valued at about $64,000. Mather Group LLC. acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $72,000. Finally, Covestor Ltd lifted its stake in DENTSPLY SIRONA by 30.8% in the first quarter. Covestor Ltd now owns 3,073 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 723 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $25.22 on Friday. The stock has a 50-day moving average price of $25.47 and a two-hundred day moving average price of $27.34. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60. The stock has a market cap of $5.24 billion, a PE ratio of -57.32, a price-to-earnings-growth ratio of 1.20 and a beta of 1.00. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.51 earnings per share. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.54%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is -145.45%.

Analysts Set New Price Targets

A number of analysts have recently commented on XRAY shares. Stifel Nicolaus lowered their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Evercore ISI reduced their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Needham & Company LLC reissued a “buy” rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Finally, Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $33.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.